Investor Relations Activity Schedule (May 22, 2024)
SDIC Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Announcement of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. on participating in the 2023 Science and Technology Innovation Board Biological Products (2) Group Performance Briefing and the 2024 First Quarter Results Briefing
Investor Relations Activity Schedule (May 7, 2024)
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Li Mingyuan)
Announcement of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. on applying for comprehensive credit and guarantee from financial institutions in 2024
China Investment Securities Co., Ltd.'s inspection opinions on Sichuan Baili Tianheng Pharmaceutical Co., Ltd. and its subsidiaries applying for comprehensive credit and guarantees from financial institutions in 2024
2023 Audit Report and Financial Statement of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Yang Min)
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Environmental, Social and Governance (ESG) Report
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Internal Control Audit Report
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. assessment report on the performance of accounting firms
Lixin Certified Public Accountants (Special General Partnership) Audit Report on the Business Income Deduction Statement of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Yu Xiong)
Special report on the storage and use of funds raised in 2023 by Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Special inspection opinion of SDIC Securities Co., Ltd. on the storage and use of funds raised by Sichuan Baili Tianheng Pharmaceutical Co., Ltd. in 2023
Audit Report of Lixin Certified Public Accountants (Special General Partnership) on the 2023 Special Report on the Storage and Use of Funds Raised by Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
Announcement of Sichuan Baili Tianheng Pharmaceutical Co., Ltd. on the renewal of the 2024 accounting firm
Announcement of Resolutions of the 12th Meeting of the Fourth Board of Supervisors of Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
SDIC Securities Co., Ltd.'s 2023 continuous supervision work site inspection report on Sichuan Baili Tianheng Pharmaceutical Co., Ltd.
No Data